跳至主要内容
临床试验/CTRI/2024/06/068246
CTRI/2024/06/068246已完成2/3 期

A SINGLE ARM CLINICAL STUDY TO EVALUATE THE EFFICACY OF ASHWATHA GHANAVATI IN THE MANEGMENT OF VATARAKTA (GOUT)

Dr. Komal Popat Sonawane1 个研究点 分布在 1 个国家目标入组 30 人开始时间: 2024年6月20日最近更新:

试验速览

阶段
2/3 期
状态
已完成
发起方
入组人数
30
试验地点
1
主要终点
reduction in symptoms: intense pain, swelling, stifness, and decrease in serum uric acid of pts.

研究概览

简要总结

TO STUDY THE EFFICACY OF ASHWATHA GHANAVATI  IN THE MANEGMENT OF VATARAKTA (GOUT) . TOTAL 30 PATIENTS WILL BE ENROLLED HAVING SYMPTOMS OF VATARAKTA(GOUT) . 2 TABLETS OF 500MG WILL BE GIVEN ADMINISTRATED TWICE A DAY ALONG WITH LUKEWARM WATER FOR DURATION OF 30 DAYS AND FOLLOW UP WILL BE DONE ON 15TH AND 30TH DAY AND FINAL CONCLUSION WILL BE DRAWN ON THE BASIS OF STATISTICAL METHOD.

研究设计

研究类型
Interventional
分配方式
Randomized
盲法
None

入排标准

年龄范围
18.00 Year(s) 至 70.00 Year(s)(—)
性别
All

入选标准

  • Patients having clinical symptoms of vatarakta like pain in joint,swelling,burning sensation,tenderness at joints , stiffness,local colour changes Sr uric acid level 3-12mg/dl.

排除标准

  • Patients with severe form of other systemic disorder like cardiac disease ,renal failure ,CAV will be excluded.
  • Pregnant women and lactating mother Injury requiring surgical interventions Any condition interfering the course of treatment were excluded Secondary hyperuricemia due to leukemia ,lypoma,polycythemia.

结局指标

主要结局

reduction in symptoms: intense pain, swelling, stifness, and decrease in serum uric acid of pts.

时间窗: 30 days study with follw up on 15th and 30th day

次要结局

  • To obeserve any adverse effect if any(30 days study follw uo on 15th, 30th day)

研究者

发起方
Dr. Komal Popat Sonawane
申办方类型
Other [(self)]
责任方
Principal Investigator
主要研究者

Dr Komal Popat Sonawane

Dr.D.Y.Patil College Of Ayurveda And Research Center Pimpri Pune

研究点 (1)

Loading locations...

相似试验